No Data
No Data
Galapagos Downgraded at Raymond James on Lack of Business Development
H.C. Wainwright Maintains Adaptimmune Therapeutics(ADAP.US) With Buy Rating, Maintains Target Price $4
JonesTrading Maintains Adaptimmune Therapeutics(ADAP.US) With Buy Rating, Cuts Target Price to $2
Agilent Technologies' MAGE-A4 Test Approved by FDA for Use With T-Cell Receptor Therapy
European Equities Traded in the US as American Depositary Receipts Sharply Down in Friday Trading
Sector Update: Health Care Stocks Decline Premarket Friday
No Data
103160675 : think its because of the black box warning of the new product ae
seewhy : The whole market is quite red today